Veracyte Inc

VCYT remains in a Stage 2 advancing regime with a clear higher-highs/higher-lows sequence above rising EMAs and the 50DMA. The primary Bullish Exhaustion pattern at marginal highs and elevated overbought readings on RSI and the Options Score signal waning near-term momentum. Price sits at resistance with long upper wicks and is extended above the EMAs, suggesting patience for a pullback into the 9/21 EMA zone before engagement. Medium-term structure is bullish, but timing conditions favor a deferred entry until support holds.

• ↑Q1 revenue $139.1M (+21% YoY); full-year guidance raised to $582–592M
• ↑Decipher test volume up 24% YoY to ~28,000 tests
• ↓Negative earnings yield and ~4.5% overvaluation weigh on valuation appeal